Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kapasi (Edmonton, Canada), K. Halloran (Edmonton, Canada), A. Hirji (Edmonton, Canada), D. Lien (Edmonton, Canada), J. Mooney (Palo Alto, United States of America), R. Raj (Palo Alto, United States of America), A. Sweatt (Palo Alto, United States of America), J. Weinkauf (Edmonton, Canada), R. Zamanian (Palo Alto, United States of America). Survival implications of pulmonary hypertension in end-stage COPD. 1426

Member's Comments

No comment yet.

Related content which might interest you: Gender-related differences in pulmonary hemodynamics in patients with end-stage COPD Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Pulmonary hemodynamics in end-stage lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2011; 39: 51-58 Year: 2012 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2012; 39: 51-58 Year: 2012 Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)? Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 Interdisciplinary rehabilitation in pulmonary hypertension: can we learn from chronic obstructive pulmonary disease or heart failure? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Improved survival in medically-treated chronic thromboembolic pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPD Source: ERJ Open Res, 6 (2) 00177-2019; 10.1183/23120541.00177-2019 Year: 2020 Secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 348s Year: 2007 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005